350 Participants Needed

Asthma Link for Childhood Asthma

MS
MT
Overseen ByMichelle Trivedi, MD
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: University of Massachusetts, Worcester
Must be taking: Inhaled corticosteroids
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The goal of this cluster Randomized Control Trial is to determine the effectiveness of Asthma Link, a school supervised asthma therapy program, compared with an educational asthma workbook, in improving asthma symptoms for children with poorly controlled asthma aged 5-14.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, since children must be prescribed a daily inhaled corticosteroid (ICS) for asthma to participate, it seems likely that they will continue with this medication during the trial.

What data supports the effectiveness of the treatment Asthma Link for childhood asthma?

Research shows that school-supervised asthma therapy, like Asthma Link, improves medication adherence and health outcomes for children with asthma. Programs that involve schools, families, and healthcare providers have been successful in managing asthma and reducing school absences due to asthma symptoms.12345

Is the Asthma Link treatment safe for children with asthma?

The Asthma Link program, which involves school-supervised asthma therapy, has been shown to improve health outcomes for children with asthma, but the available research does not specifically address safety concerns. It focuses on improving asthma management and coordination among schools, families, and healthcare providers.12356

How is the Asthma Link treatment different from other asthma treatments?

Asthma Link is unique because it involves school-supervised therapy, where children receive their asthma medication at school, improving adherence and health outcomes. This approach is designed to be sustainable and low-cost, making it easier to adopt in real-world settings compared to traditional home-based treatments.12678

Research Team

MT

Michelle Trivedi, MD

Principal Investigator

UMass Chan Medical School

Eligibility Criteria

This trial is for children aged 5-14 with poorly controlled asthma. It's designed to see if a school program called Asthma Link can help manage their symptoms better than an educational workbook.

Inclusion Criteria

Child: Meet the eligibility criteria for Asthma Link, Enrolled in Asthma Link (if randomized to the Asthma Link Condition), Able and willing to provide informed assent
I am over 18, speak English or Spanish, and can consent for my child.

Exclusion Criteria

My child cannot give informed assent due to developmental delays.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Children receive school-supervised asthma therapy or an educational asthma workbook

6 months
Regular school visits for therapy administration

Follow-up

Participants are monitored for asthma control and medication adherence

6 months
Surveys and assessments at 6 and 12 months

Treatment Details

Interventions

  • Asthma Link
  • Enhanced Usual Care
Trial Overview The study is testing the effectiveness of 'Asthma Link', which involves supervised asthma therapy at school, against just using an educational workbook on asthma care. Children will be randomly placed in one of these two groups.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Asthma LinkExperimental Treatment1 Intervention
Practices in the Asthma Link condition will receive brief training on how to identify, refer and arrange for children with poorly controlled asthma to receive school-supervised therapy with the child's school health staff. Participants will receive an educational asthma workbook.
Group II: Enhanced Usual CareActive Control1 Intervention
Practices in the Enhanced Usual Care condition will receive brief training on how to identify and refer the same group of children with poorly controlled asthma and these children will receive an educational asthma workbook.

Asthma Link is already approved in United States for the following indications:

🇺🇸
Approved in United States as Asthma Link for:
  • Poorly controlled asthma in children aged 5-14

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Massachusetts, Worcester

Lead Sponsor

Trials
372
Recruited
998,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Findings from Research

Asthma Link™ is a promising low-cost model for school-supervised inhaled corticosteroid therapy that has shown significant improvements in health outcomes for children with asthma, based on qualitative feedback from 29 participants.
Stakeholders identified key facilitators for success, such as simple procedures and positive health impacts, but also noted barriers like protocol deviations and insurance coverage issues, along with proposed solutions to enhance the program's real-world adoption.
Alignment of stakeholder agendas to facilitate the adoption of school-supervised asthma therapy.Trivedi, M., Patel, J., Hoque, S., et al.[2021]
Children with asthma often miss more school than their healthy peers due to uncontrolled symptoms, highlighting the need for effective management strategies.
The School-based Asthma Management Program, which includes four key components, has been shown to improve communication and coordination of care among families, clinicians, and schools, ultimately helping to manage asthma more effectively.
Asthma in Schools: How School-Based Partnerships Improve Pediatric Asthma Care.Kakumanu, S., Lemanske, RF.[2019]
The Building Bridges for Asthma Care Program, implemented in 28 schools across Colorado and Connecticut, successfully coordinated asthma management by engaging families, health providers, and schools, leading to significant improvements in asthma care plans and inhaler techniques.
Key outcomes included increased completion of School Asthma Care Plans and Home Asthma Action Plans, as well as better access to quick-relief inhalers at school, demonstrating the program's effectiveness in supporting at-risk children with asthma.
Building Bridges for Asthma Care Program: A School-Centered Program Connecting Schools, Families, and Community Health-Care Providers.Cicutto, L., Gleason, M., Haas-Howard, C., et al.[2023]

References

Alignment of stakeholder agendas to facilitate the adoption of school-supervised asthma therapy. [2021]
Asthma in Schools: How School-Based Partnerships Improve Pediatric Asthma Care. [2019]
Building Bridges for Asthma Care Program: A School-Centered Program Connecting Schools, Families, and Community Health-Care Providers. [2023]
Creation and implementation of SAMPRO™: A school-based asthma management program. [2019]
Incorporating systems-level stakeholder perspectives into the clinical trial design of school-supervised asthma therapy. [2022]
Allergic rhinitis co-morbidity on asthma outcomes in city school children. [2023]
Sustaining school-based asthma interventions through policy and practice change. [2018]
Effectiveness of a modified open airways curriculum. [2015]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security